Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective study

Mauro G. Trovò; Umberto Tirelli; Antonino De Paoli; Giovanni Franchin; Mario Roncadin; M. Donatella Magri; Enzo Galligioni; Andrea Veronesi; Salvatore Tumolo; Antonino Carbone; Eligio Grigoletto

doi:10.1016/0360-3016(82)90176-6

Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective study

Mauro G. Trovò, Umberto Tirelli, Antonino De Paoli, Giovanni Franchin, Mario Roncadin, M. Donatella Magri, Enzo Galligioni, Andrea Veronesi, Salvatore Tumolo, Antonino Carbone, Eligio Grigoletto

Centro di Riferimento Oncologico

Research output: Contribution to journal › Article › peer-review

Abstract

Sixty-four consecutive patients with inoperable epidermoid bronchogenic carcinoma (limited disease) were treated with radiotherapy to the primary and nodal areas and combination chemotherapy with cyclophosphamide, adriamycin, methotrexate and procarbazine. The overall response rate (CR + PR) to combined treatment was 62%. The median survival time was 12.7 months. The toxicity was acceptable and no treatment-related death occurred.

Original language	English
Pages (from-to)	1051-1054
Number of pages	4
Journal	International Journal of Radiation Oncology Biology Physics
Volume	8
Issue number	6
DOIs	https://doi.org/10.1016/0360-3016(82)90176-6
Publication status	Published - 1982

Keywords

Combined radio- and chemotherapy
Epidermoid bronchogenic carcinoma
Lung cancer

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging
Radiation

Access to Document

10.1016/0360-3016(82)90176-6

Fingerprint

Dive into the research topics of 'Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective study'. Together they form a unique fingerprint.

Cite this

Trovò, M. G., Tirelli, U., De Paoli, A., Franchin, G., Roncadin, M., Donatella Magri, M., Galligioni, E., Veronesi, A., Tumolo, S., Carbone, A., & Grigoletto, E. (1982). Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective study. International Journal of Radiation Oncology Biology Physics, 8(6), 1051-1054. https://doi.org/10.1016/0360-3016(82)90176-6

Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease : A prospective study. / Trovò, Mauro G.; Tirelli, Umberto; De Paoli, Antonino; Franchin, Giovanni; Roncadin, Mario; Donatella Magri, M.; Galligioni, Enzo; Veronesi, Andrea; Tumolo, Salvatore; Carbone, Antonino; Grigoletto, Eligio.

In: International Journal of Radiation Oncology Biology Physics, Vol. 8, No. 6, 1982, p. 1051-1054.

Research output: Contribution to journal › Article › peer-review

Trovò, MG, Tirelli, U, De Paoli, A, Franchin, G, Roncadin, M, Donatella Magri, M, Galligioni, E, Veronesi, A, Tumolo, S, Carbone, A & Grigoletto, E 1982, 'Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective study', International Journal of Radiation Oncology Biology Physics, vol. 8, no. 6, pp. 1051-1054. https://doi.org/10.1016/0360-3016(82)90176-6

Trovò MG, Tirelli U, De Paoli A, Franchin G, Roncadin M, Donatella Magri M et al. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective study. International Journal of Radiation Oncology Biology Physics. 1982;8(6):1051-1054. https://doi.org/10.1016/0360-3016(82)90176-6

Trovò, Mauro G. ; Tirelli, Umberto ; De Paoli, Antonino ; Franchin, Giovanni ; Roncadin, Mario ; Donatella Magri, M. ; Galligioni, Enzo ; Veronesi, Andrea ; Tumolo, Salvatore ; Carbone, Antonino ; Grigoletto, Eligio. / Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease : A prospective study. In: International Journal of Radiation Oncology Biology Physics. 1982 ; Vol. 8, No. 6. pp. 1051-1054.

@article{944c2d1676c14784bc94558ec712fa90,

title = "Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective study",

abstract = "Sixty-four consecutive patients with inoperable epidermoid bronchogenic carcinoma (limited disease) were treated with radiotherapy to the primary and nodal areas and combination chemotherapy with cyclophosphamide, adriamycin, methotrexate and procarbazine. The overall response rate (CR + PR) to combined treatment was 62%. The median survival time was 12.7 months. The toxicity was acceptable and no treatment-related death occurred.",

keywords = "Combined radio- and chemotherapy, Epidermoid bronchogenic carcinoma, Lung cancer",

author = "Trov{\`o}, {Mauro G.} and Umberto Tirelli and {De Paoli}, Antonino and Giovanni Franchin and Mario Roncadin and {Donatella Magri}, M. and Enzo Galligioni and Andrea Veronesi and Salvatore Tumolo and Antonino Carbone and Eligio Grigoletto",

year = "1982",

doi = "10.1016/0360-3016(82)90176-6",

language = "English",

volume = "8",

pages = "1051--1054",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease

T2 - A prospective study

AU - Trovò, Mauro G.

AU - Tirelli, Umberto

AU - De Paoli, Antonino

AU - Franchin, Giovanni

AU - Roncadin, Mario

AU - Donatella Magri, M.

AU - Galligioni, Enzo

AU - Veronesi, Andrea

AU - Tumolo, Salvatore

AU - Carbone, Antonino

AU - Grigoletto, Eligio

PY - 1982

Y1 - 1982

N2 - Sixty-four consecutive patients with inoperable epidermoid bronchogenic carcinoma (limited disease) were treated with radiotherapy to the primary and nodal areas and combination chemotherapy with cyclophosphamide, adriamycin, methotrexate and procarbazine. The overall response rate (CR + PR) to combined treatment was 62%. The median survival time was 12.7 months. The toxicity was acceptable and no treatment-related death occurred.

AB - Sixty-four consecutive patients with inoperable epidermoid bronchogenic carcinoma (limited disease) were treated with radiotherapy to the primary and nodal areas and combination chemotherapy with cyclophosphamide, adriamycin, methotrexate and procarbazine. The overall response rate (CR + PR) to combined treatment was 62%. The median survival time was 12.7 months. The toxicity was acceptable and no treatment-related death occurred.

KW - Combined radio- and chemotherapy

KW - Epidermoid bronchogenic carcinoma

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=0019962418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019962418&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(82)90176-6

DO - 10.1016/0360-3016(82)90176-6

M3 - Article

C2 - 7107434

AN - SCOPUS:0019962418

VL - 8

SP - 1051

EP - 1054

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 6

ER -

Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective study

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this